Tesamorelin

---

 Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that has been studied for its effects on growth hormone secretion and metabolic regulation. 

•  Visceral fat reduction 
• Growth hormone stimulation 
• Metabolic function

•  Stimulates pituitary release of growth hormone 
• Influences IGF-1 levels 
• May affect lipid metabolism

 Human Studies:

• Demonstrated reduction in visceral adipose tissue in clinical settings 
• Improvements in certain metabolic markers 

Preclinical Data:

• Supports endocrine pathway activity

•  Human Evidence: Moderate 
• Animal Evidence: Moderate 
• Mechanistic Support: Strong 
• Long-Term Safety: Moderat

•  Effects may reverse after discontinuation 
• Primarily studied in specific populations 
• Not broadly studied for general optimization

•  Tesamorelin has some of the stronger human data among peptides, particularly in metabolic research contexts